Magnetoencephalography in Children
ID: NCT06668519
Our intelligence engine has synthesized this trial record to answer your most important questions in clear, simple terms:
This study is a single-center observational clinical study, which evaluates the diagnostic value of magnetoencephalography (MEG) in the diagnosis of neurodevelopmental diseases in children, such as the localization of epileptic foci and brain functional areas, intracranial tumors, cerebrovascular diseases, autism, mental retardation, and neuropsychiatric disorders.
Read Full Scientific Objectives & Methods
The purpose of this study is to observe the application of magnetoencephalography (MEG) in pediatric neurodevelopmental disorders
Magnetoencephalography
Treatment Arms Description
- aged 1 month-18 years old (date of investigate minus date of birth)
- epilepsy
- intracranial tumors
- cerebrovascular diseases
- autism
- mental retardation
- ADHD
- tic disorder
- neuropsychiatric disorders
- Unable to cooperate with the exam of MEG
Primary Outcome Measures
- Difference in magnetoencephalography (MEG) signal between children with neurodevelopmental diseases and healthy children — Time Frame: 3 years
Acquisition of magnetoencephalography (MEG) signals based on Inclusion Criteria
This trial is recruiting at 1 study facilities worldwide. Click below to see if there is a clinic or hospital in your area:
Show All 1 Facilities & Contact Sites
Want to apply or inquire about joining this study? Fill out this simple questionnaire, and our assistant will instantly generate a professional email draft you can copy and send to the central contact coordinator listed above!
View Official Medical/Scientific Title
An Observational Study on the Clinical Application of Magnetoencephalography in Children With Neurodevelopmental Disorders